UCSD GTI Symposium (Gene Therapy Initiative) 2026
Join Pharmaron from September 16 – 17 for the UCSD Gene Therapy Initiative Symposium 2026
Pharmaron’s CGT team is joining UCSD’s Gene Therapy Initiative at the Salk Institute in La Jolla, California. Pharmaron’s integrated CGT services span from discovery through commercialization, making any CGT project seamless. Make sure to stop by our booth to discuss how we can accelerate and strengthen your CGT programs.
Event Details:
- September 16 – 8:30 a.m. – 6:30 p.m.
- September 17 – 8:30 a.m. – 6:30 p.m.
- Conrad T. Prebys Auditorium, The Salk Institute, La Jolla, CA
- 10010 N. Torrey Pines Rd, La Jolla, CA 92037
Connect with us
Schedule a meeting with our team to discuss your upcoming projects and learn how Pharmaron can support your CGT success. Request a meeting by filling out the form below!
Our GTI Symposium Schedule
Our Cell & Gene Therapy Capabilities
Pharmaron offers comprehensive laboratory services designed to support the development of cell and gene therapy (CGT) products at every stage, from discovery and preclinical studies through clinical development and commercialization.
Our CGT laboratory technologies include:
Manager of Business Development
US Labs, Cell & Gene Therapy
Associate Director of Business Development
Ophthalmology, Cell & Gene Therapy
- in vitro Assays – Development and validation of robust, reliable methods to support the analysis of CGT products
- in vivo Studies – Expertise in disease models for efficacy, safety, and pharmacokinetics
- Biodistribution and viral shedding – Advanced bioanalytical methods to assess vector presence and gene expression
- Cell and Gene Therapy (CGT) bioanalysis – Assay development to characterize CGT products and support regulatory submissions
- Cell and Gene Therapy (CGT) Ophthalmology Services – Ocular disease models and diverse dose routes for translational preclinical evaluation
- Cell and Gene Therapy (CGT) Safety Assessment – Addresses preclinical safety evaluation needs to support IND and BLA filings with regulatory agencies (FDA/EMA/NMPA)
Our modalities include medicinal products using AAV (various serotypes), viral and non-viral vectors, and cell-based therapeutics. We conduct studies under GLP, GCP, GCLP, and GMP guidelines, supporting IND and BLA submissions to FDA, EMA, NMPA, and other global regulatory agencies. Our capabilities also extend to clinical and commercial batch release, ensuring regulatory compliance and quality at every step.
If you’re attending, visit our table to meet with our team and discuss your upcoming projects to learn how Pharmaron can partner with you to accelerate your CGT programs. If you’re unable to attend, click the option on this page to schedule a meeting with Mani and Natalie to discuss your needs and learn how our flexible and integrated services can help bring your vision to reality.
About the Gene Therapy Initiative (GTI) Symposium 2026
The UCSD Gene Therapy Initiative symposium is a partnership between UC San Diego, California Life Sciences and CIRM. This event offers a two-day experience for attendees to learn more about the future of cell & gene therapy and network with fellow CGT peers.
For more information and event registration, please visit the UC San Diego website.
Request a Meeting
Meeting Request Form
Meeting requests during a conference or event
